Skip to main content
NIH funding notice PAR-16-331

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)

Closed on September 11, 2018.

Posted
June 15, 2016
Close date
September 11, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,529,582 in first-year total cost, median $692,593.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 MDCN-B (50)]8

Most frequent institutions

  1. DUKE UNIVERSITY1
  2. NATIONAL JEWISH HEALTH1
  3. RBHS-SCHOOL OF PUBLIC HEALTH1
  4. UNIVERSITY OF CALIFORNIA AT DAVIS1
  5. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
Competing awards under PAR-16-331 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Dexamethasone as an Effective Therapy for Ocular Injuries by Vesicating Agents.1U01EY030405-01AGARWAL, RAJESHUNIVERSITY OF COLORADO DENVER, CO$727,496ZRG1
2019Advanced TRPA1 Inhibitor for the Treatment of Chlorine Inhalation Injury1U01ES030672-01ACHANTA, SATYANARAYANAJORDT, SVEN-ERICDUKE UNIVERSITY, NC$750,625ZRG1
2019Development of IM Formulation of (2S,3S)-SPD for Nerve Agent Seizures1U01NS112102-01BIALER, MEIRROGAWSKI, MICHAEL A.UNIVERSITY OF CALIFORNIA AT DAVIS, CA$652,636ZRG1
2019Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning1U01NS112125-01PATTERSON, STEVEN EUNIVERSITY OF MINNESOTA, MN$571,768ZRG1
2018Optimization of AEOL10150 treatment of sulfur mustard-induced lung toxidrome in a pig model1U01ES029430-01DAY, BRIAN JNATIONAL JEWISH HEALTH, CO$812,406ZRG1
2018Advanced Development of Drugs to Mitigate Parathion Intoxication1U01NS108956-01LASKIN, JEFFREY DRICHARDSON, JASON RRBHS-SCHOOL OF PUBLIC HEALTH, NJ$802,842ZRG1
2017Sodium Tetrathionate as a Cyanide Antidote1U01NS105057-01BOSS, GERRY RUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$657,690ZRG1
2017Novel Counteract Agents To Reduce Mortality And Morbidity Following Organophosphate Status Epilepticus1U01NS105058-01DELORENZO, ROBERT JOHNVIRGINIA COMMONWEALTH UNIVERSITY, VA$554,119ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-16-331: Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01) | ScienceDex | ConductScience